AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
Our most advanced programs are currently in vivo optimization.

AQEMIA is based in Paris and London.

AI/ML

Biotechnology

Chemicals

Pharmaceutical

Software

AQEMIA

Paris

London

Maximilien Levesque

Sylvain Sabi

Emmanuelle Martiano Rolland

Théa Vu - Bignand

Aurore Lejeune

Dr Veronique Birault Fmedsci

Orianne Bornand

Nicolas Canouï

Ingrid  Delval

Founders

People (1)

Maximilien Levesque

Jobs